海外の治験の状況「1」での検索結果
2039件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- GLP-1 analogs for Freidreich's Ataxia treatment.
- Friedreich's Ataxia;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Belgium
- 2014-09-08
Authorised
- A pilot study to assess the impact of genetic polymorphisms in the ABCB1 and ABCG2 genes on brain and organ penetration of dual Pgp/BCRP substrates in humans.
- The effect of genetic polymorphisms on drug distribution will be investigated in healthy volunteers;Therapeutic area: Body processes [G] - Genetic Phenomena [G05]
- Austria
- 2014-03-19
Authorised
- Multi-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer.
- Unresectable Wild-Type KRAS Metastatic Colorectal Cancer MedDRA version: 16.0 Level: LLT Classification code 10052362 Term: Metastatic colorectal cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Austria, Belgium, France, Ireland, Israel, Italy, Spain
- 2013-05-22
Authorised
- Primary prevention of type 1 diabetes in young children at high risk for type 1 diabetes using intranasal insulin
- Risk for type 1 diabetes;Therapeutic area: Diseases [C] - Immune System Diseases [C20];Risk for type 1 diabetes;Therapeutic area: Diseases [C] - Immune System Diseases [C20];Risk for type 1 diabetes;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Germany
- 2016-09-02
Authorised
- Trial aimed at evaluating the activity of the anti-ALK1 monoclonal antibody PF-03446962 in relapsed or refractory urothelial cancer (UC) failing first-line treatment.
- Relapsed or refractory urothelial cancer after failure of 1st line platinum-containing chemotherapy regimen for metastatic disease. MedDRA version: 14.1 Level: HLT Classification code 10038502 Term: Renal pelvis and ureter neoplasms malignant System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: PT Classification code 10044410 Term: Transitional cell cancer of the renal pelvis and ureter recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: PT Classification code 10044412 Term: Transitional cell carcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: PT Classification code 10066750 Term: Bladder transitional cell carcinoma recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Italy
- 2012-03-07
Authorised
- Does targeting of S1P receptors reduce microglial activation in multiple sclerosis?
- Multiple sclerosis MedDRA version: 14.1 Level: PT Classification code 10028245 Term: Multiple sclerosis System Organ Class: 10029205 - Nervous system disorders
- Finland
- 2013-11-20
Authorised
- First-line treatment for different subgroups of lymphomas
- Indolent Non-Hodgkin Lymphomas, in particular follicular lymphomas, as well as marginal zone lymphomas, immunocytomas (Waldenström’s macroglobulinaemia) and mantle cell lymphomas;Therapeutic area: Diseases [C] - Cancer [C04]
- Austria, Germany
- 2008-11-20
Authorised
- Does subcutaneous interleukin-1 receptor antagonist reduce inflammation following subarachnoid haemorrhage? - SC IL-1Ra in SAH
- Subarachnoid haemorrhage MedDRA version: 14.0 Level: PT Classification code 10042316 Term: Subarachnoid haemorrhage System Organ Class: 10029205 - Nervous system disorders
- United Kingdom
- 2011-06-23
Authorised
- The additive effect of the appetite hormone GLP-1 (liraglutide) and exercise on maintenance of weight loss and on health parameters after a low calorie diet
- Obesity MedDRA version: 20.0 Level: PT Classification code 10029883 Term: Obesity System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Denmark
- 2016-05-11
Authorised
- iVAC-CLL01: Patient-individualized peptide vaccination after first line therapy of CLL
- Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) after first line therapy MedDRA version: 20.0 Level: LLT Classification code 10009310 Term: CLL System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Germany
- 2016-04-13